New Vaccines for PRRSV in Pigs
Author Information
Author(s): Xie Chang-zhan, Zhang Ping, Wang Zheng, Tao Yi-mo, Cui Zhuo-dong, Nan Fu-long, Zhang Fu-chao, Ren Yun-xin, Zhang He, Lu Hui-jun
Primary Institution: Chinese Academy of Agricultural Sciences
Hypothesis
Can recombinant adenovirus vaccines effectively protect pigs against the newly emerged NADC34-like PRRSV strain?
Conclusion
The recombinant adenovirus vaccines provide good protective immunity and induce both humoral and cellular immune responses in pigs.
Supporting Evidence
- Vaccinated animals showed significantly higher levels of IFN-γ and IL-4 cytokines compared to control groups.
- Immunized pigs did not exhibit clinical symptoms after being challenged with the virus.
- The recombinant vaccines reduced viremia and showed lower viral loads in tissues compared to control groups.
Takeaway
Scientists created new vaccines to help protect pigs from a virus that makes them sick, and the vaccines worked well.
Methodology
The study involved constructing recombinant adenovirus vaccines and testing their immunogenicity in piglets by measuring specific antibodies and cytokines after vaccination.
Participant Demographics
Weaned piglets aged 4-5 weeks.
Statistical Information
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website